Solid Biosciences (SLDB) Cash from Operations (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Cash from Operations for 8 consecutive years, with 29645000.0 as the latest value for Q4 2024.
- Quarterly Cash from Operations fell 42.37% to 29645000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 100012000.0 through Dec 2024, down 6.19% year-over-year, with the annual reading at 156289000.0 for FY2025, 56.27% down from the prior year.
- Cash from Operations hit 29645000.0 in Q4 2024 for Solid Biosciences, down from 23708000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1307000.0 in Q4 2020 to a low of 34480000.0 in Q4 2022.
- Historically, Cash from Operations has averaged 21326600.0 across 5 years, with a median of 21120000.0 in 2021.
- Biggest five-year swings in Cash from Operations: skyrocketed 106.15% in 2020 and later crashed 1697.09% in 2021.
- Year by year, Cash from Operations stood at 1307000.0 in 2020, then plummeted by 1697.09% to 20874000.0 in 2021, then plummeted by 65.18% to 34480000.0 in 2022, then surged by 39.61% to 20823000.0 in 2023, then tumbled by 42.37% to 29645000.0 in 2024.
- Business Quant data shows Cash from Operations for SLDB at 29645000.0 in Q4 2024, 23708000.0 in Q3 2024, and 21467000.0 in Q2 2024.